Psychiatr. pro Praxi, 2008; 9(3): 140-142

Bupropion v ambulantní praxi

prof. MUDr. Alexandra Žourková CSc
Psychiatrická klinika LF MU a FN Brno

Sdělení podává přehled o indikacích a kontraindikacích bupropionu při antidepresivní léčbě. Je probrána úspěšnost augmentace léčby nejčastěji předepisovaných selektivních inhibitorů zpětného vychytávání serotoninu bupropionem, účinnost bupropionu při léčbě úzkostných poruch i jeho výhody v porovnání s ostatními antidepresivy (není riziko váhového příbytku, sexuálních dysfunkcí). Účinnost bupropionu je ilustrována kazuistikami z ambulantní praxe.

Keywords: bupropion, depresivní porucha, augmentace léčby, úzkostné poruchy, kazuistiky

Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A. Bupropion v ambulantní praxi. Psychiatr. praxi. 2008;9(3):140-142.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clayton AH, Warnock JJ, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitors-induced sexual dysfunction, J. Clin. Psychiatry, 2004, 65: 62-67. Go to original source... Go to PubMed...
    2. Clayton AH. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?, Expert Opin. Pharmacother. 2007, 8: 457-466. Go to original source... Go to PubMed...
    3. Foley KF, DeSanty KP, Kast RE. Bupropion: pharmacology and therapeutic applications, Expert Rev. Neurother. 2006, 6: 1249-1265. Go to original source... Go to PubMed...
    4. Švestka J. Bupropion - dopaminergní a noradrenergní antidepresivum, Psychiatrie, 2001, 5: 196-209.
    5. Thase ME, Friedman E, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon S, Rush AJ. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report, Am. J. Psychiatry, 2007, 164: 739-752. Go to original source... Go to PubMed...
    6. Žourková A. Bupropion-více než antidepresivum, Remedia, 2007, 17: 592-594.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.